Clinical Trials Logo

Tourette Syndrome clinical trials

View clinical trials related to Tourette Syndrome.

Filter by:

NCT ID: NCT04007991 Completed - Tourette Syndrome Clinical Trials

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

D1AMOND
Start date: June 28, 2019
Phase: Phase 2
Study type: Interventional

This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets

NCT ID: NCT04007913 Completed - Tourette Syndrome Clinical Trials

Incorporating teleCBIT Into a Hospital-Based Tic Program

Start date: September 21, 2016
Phase: N/A
Study type: Interventional

This is a single-arm open trial of Comprehensive Behavioral Intervention for Tics (CBIT) delivered to pediatric and adult patients with persistent tic disorders in their homes via videoconferencing (i.e., teleCBIT). All participants who enroll will receive teleCBIT.

NCT ID: NCT03958617 Completed - Tourette Syndrome Clinical Trials

Thalamic Deep Brain Stimulation for Tourette Syndrome

Start date: May 1, 2014
Phase: Phase 2/Phase 3
Study type: Interventional

In this single-center trial, we aim to include 8 patients with severe and medically refractory Tourette's syndrome. All patients undergo deep brain stimulation surgery with two electrodes located in the centromedian-parafascicular complex. Tic severity and secondary outcome measurements are assessed six and twelve months after surgery. Additionally, a short randomized, double-blinded sham controlled crossover sequence of 24 to 48 hours in either active or sham stimulation is implemented after both 6 and 12 months assesments. Subjects and clinicians are blinded to treatment allocation.

NCT ID: NCT03916055 Completed - Tourette's Disorder Clinical Trials

Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder

Start date: April 26, 2019
Phase: N/A
Study type: Interventional

The purpose of this trial is to evaluate the clinical efficacy, 12-month durability, and cost-effectiveness of BIP TIC - a therapist-guided and parent-guided internet-delivered behavioural intervention for children and adolescents with Tourette's Disorder and Persistent (Chronic) Motor or Vocal Tic Disorder.

NCT ID: NCT03771235 Completed - Tourette Syndrome Clinical Trials

Online Mindfulness-based Tic Reduction (Phase Two)

Start date: November 9, 2018
Phase: N/A
Study type: Interventional

Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments or find them unacceptable. Thus, it is essential that researchers continue to develop and test novel treatment approaches. In this randomized controlled trial the investigators will compare two different online group-based interventions for tics: a mindfulness-based program (Mindfulness-based Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic Information and Coping Strategies (TICS)). The purpose of this study is to determine which intervention is more helpful for adults with a tic disorder.

NCT ID: NCT03765463 Completed - Clinical trials for Tourette Syndrome in Adolescence

Extinction Learning in Youth With Tourette Syndrome

Start date: February 28, 2019
Phase: N/A
Study type: Interventional

Aversive sensory phenomena such as premonitory urges play a central role in the behavioral treatment model of tics. Extinction learning and extinction recall are learning processes implicated within this model, but have not been directly evaluated in youth with Tourette syndrome (TS). This study examines extinction learning and extinction recall in youth with TS using an experimental task. This study will also explore the relationship between extinction processes (i.e., extinction learning and extinction recall) and treatment outcomes with behavior therapy. Findings from this investigation will be used to update the behavioral treatment model, which serves as the basis for evidence-based behavioral interventions.

NCT ID: NCT03628703 Completed - Tourette Syndrome Clinical Trials

Response Inhibition in Tourette Syndrome

Start date: April 22, 2019
Phase: N/A
Study type: Interventional

Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).

NCT ID: NCT03625453 Completed - Tourette Syndrome Clinical Trials

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Start date: October 15, 2018
Phase: Phase 2
Study type: Interventional

Two-part study consisting of a double-blind, randomized, placebo-controlled, study at two target dose levels (Part 1) and an open-label, non-randomized study (Part 2) to determine the efficacy of ABX-1431 in treating adult patients with Tourette syndrome or Chronic Motor Tic Disorder as measured by the change from baseline in Total Tic Score of the Yale Global Tic Severity Scale (YGTSS-TTS) compared with placebo.

NCT ID: NCT03621059 Completed - Tourette Syndrome Clinical Trials

Behavioral Therapy for Children and Adolescents With Tourette Syndrome

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Tourette Syndrome (TS) is a common neuropsychiatric disorder in childhood and adolescence, and often comorbid with psychiatric comorbidity. Antipsychotic medications are usually the first choices, but may associate with adverse effects. Behavioral intervention for TS has been shown to be an effective treatment for children and adolescents, yet have not been performed and evaluated using control trails in Taiwan.

NCT ID: NCT03604510 Completed - Tourette Syndrome Clinical Trials

Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS)

TIC-EEG
Start date: February 2, 2018
Phase: N/A
Study type: Interventional

Tourette's syndrome (TS) is a debilitating and severe syndrome whose pathophysiology remains unclear. In order to precise the cortical regions involved in the generation of tics, investigators will realize an electroencephalogram (EEG) recording in the frontal cortex of TS patients in ecological conditions (EEG-holter). Activity changes will be correlated with event markers of tics and neurovegetative parameters. Statistical analyses will be compared between epochs of EEG recording with tics and without tics. The aim is to define the cortical regions involved in the genesis of tics in order to consider new targets for cortical stimulation.